STAAR Surgical Company (STAA)
NASDAQ: STAA · Real-Time Price · USD
18.46
-0.11 (-0.59%)
Mar 6, 2026, 4:00 PM EST - Market closed

Company Description

STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, and sells phakic implantable lenses for the eye and accessory delivery systems to deliver the lenses into the eye.

The company offers implantable collamer lens product family (ICLs) comprising EVO ICL, EVO+ ICL, EVO Visian ICL, and EVO Viva ICL for use in refractive surgery for the treatment of visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia.

It serves health care providers, including ophthalmic surgeons, vision and surgical centers, hospitals, government facilities, and distributors, as well as ophthalmologists.

The company sells its products directly through its sales representatives in Japan, the United States, Germany, Spain, Singapore, Canada, and the United Kingdom, as well as through representatives and independent distributors in China, Korea, India, France, Benelux, Italy, and internationally.

STAAR Surgical Company was incorporated in 1982 and is headquartered in Lake Forest, California.

STAAR Surgical Company
STAAR Surgical Company logo
Country United States
Founded 1982
Industry Medical Instruments & Supplies
Sector Healthcare
Employees 1,157
CEO Stephen Farrell

Contact Details

Address:
25510 Commercentre Drive
Lake Forest, California 92630
United States
Phone 626 303 7902
Website staar.com

Stock Details

Ticker Symbol STAA
Exchange NASDAQ
Stock Type Common Stock
Fiscal Year February - January
Reporting Currency USD
CIK Code 0000718937
CUSIP Number 852312305
ISIN Number US8523123052
Employer ID 95-3797439
SIC Code 3851

Key Executives

Name Position
Deborah J. Andrews Interim Co-Chief Executive Officer and Chief Financial Officer
Warren Foust Interim Co-Chief Executive Officer, President and Chief Operating Officer
Dr. Magda Michna Ph.D. Chief Development Officer
Nathaniel B. Sisitsky Esq. Consultant
Nancy Sabin Chief Marketing Officer
Dr. Scott D. Barnes M.D. Chief Medical Officer

Latest SEC Filings

Date Type Title
Mar 3, 2026 8-K Current Report
Mar 3, 2026 10-K Annual Report
Feb 5, 2026 8-K Current Report
Feb 2, 2026 8-K Current Report
Jan 16, 2026 SCHEDULE 13D/A Filing
Jan 16, 2026 SCHEDULE 13D/A Filing
Jan 16, 2026 8-K Current Report
Jan 15, 2026 8-K Current Report
Jan 8, 2026 SCHEDULE 13D/A Filing
Jan 6, 2026 8-K Current Report